Investing.com - Stifel has raised its price target on Structure Therapeutics (NASDAQ:GPCR) to $90.00 from $50.00 while maintaining a Buy rating on the stock. The new target represents nearly 30% ...

Lattice structures underpin much of modern materials science, providing a fundamental framework to understand the arrangement of atoms, electrons, or quasi-particles in a variety of physical systems.

Investing.com - H.C. Wainwright raised its price target on Structure Therapeutics (NASDAQ:GPCR) to $90.00 from $60.00 on Monday, while maintaining a Buy rating on the stock. This aligns with the ...

A pill from Structure Therapeutics Inc. helped patients lose roughly as much weight as a rival treatment from Eli Lilly & Co., giving the startup an edge as it seeks to break into the highly ...

New lithium battery structure breakthrough targets EVs, aircraft with 90% retention Researchers at the Gyeongsang National ...

Our team of savvy editors independently handpicks all recommendations. If you make a purchase through our links, we may earn a commission. Deals and coupons were accurate at the time of publication ...

H.C. Wainwright analyst Ananda Ghosh raised the firm’s price target on Structure Therapeutics (GPCR) to $90 from $60 and keeps a Buy rating on the shares. The firm says its key opinion leader feedback ...

SABINE PASS, Texas — A liquefied natural gas (LNG) “cool down cargo” from Ras Laffan, Qatar has berthed at the Golden Pass LNG terminal in Sabine Pass, Texas, marking a major step toward the ...

A limited liability company (LLC) is a business structure combining the tax advantages of a partnership with the liability protections of a corporation. Many, or all, of the products featured on this ...